Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
-8.89x4.14x-0.23x3.94x-7.28x-6.83x-.--% 2.21B
17.24x1.95x-1.95x3.69x9.5x11.02x0.59% 66.32B
26.03x3.94x1.88x5.39x15.83x19.62x0.6% 52.6B
33.71x6.94x0.63x11.47x21.71x25.74x-.--% 43.27B
-42.82x2.4x0.33x3.08x9.11x10.63x3.53% 38.64B
24.39x1.59x-3.79x3.47x11.8x13.68x-.--% 29.62B
56.3x4.18x-0.83x3.29x27.65x28.03x-.--% 23.31B
-6.59x3.99x-0.34x9.17x-5.65x-5.29x-.--% 22.62B
65.79x5.91x0.43x6.47x44.55x50.25x-.--% 20.22B
24.1x3.53x0.02x5.16x13.51x18.67x-.--% 16.29B
-37.28x-6.61x0.91x17.78x-48.68x-56.26x-.--% 16.26B
-117.16x12792.9x2.66x12.58x-90.09x-125.57x-.--% 12.43B
17.43x - 0.2x3.59x13.87x16.19x-.--% 11.38B
43.85x - 4.78x - - - -.--% 9.65B
56.08x22.87x0.53x33.96x48.03x49.53x0.17% 11.13B
12.47x1.11x0.45x1.83x7.37x9.96x2.76% 6.46B
-45.67x - -0.82x - - - - 5.76B
62.15x4.39x-0.8x - - - - 5.9B
Average 10.06x 856.88x 0.22x 8.32x 4.75x 3.96x 0.48% 21.89B
Weighted average by Cap. 13.38x 436.54x -0.07x 7.05x 9.53x 10.34x 0.59%
Biopharmaceuticals